Global Immunohistochemistry Market is Projected to Reach USD 4.7 Billion by 2028

The global Immunohistochemistry Market is poised for remarkable expansion, according to the latest report titled "Immunohistochemistry Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics [Cancer, Infectious, Autoimmune Diseases], Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028." The market is projected to soar from USD 3.2 billion in 2023 to an estimated USD 4.7 billion by 2028, with a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2023 to 2028.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939

Key Drivers of Market Growth

The growth of the Immunohistochemistry Market is underpinned by several key factors:

1. Rising Geriatric Population: The increased population of the elderly, who often require advanced diagnostic and therapeutic solutions, is a significant driver of market growth. Immunohistochemistry (IHC) plays a pivotal role in diagnosing and managing diseases prevalent in the elderly population.

2. Escalating Cancer Incidence: With the growing incidence of cancer cases worldwide, the demand for accurate and reliable diagnostic methods has surged. IHC offers precise insights into cancer diagnosis and prognosis, fueling its adoption.

3. Technological Advancements: Continuous advancements in IHC technology have improved its accuracy and efficiency. The availability of advanced equipment, antibodies, reagents, and kits has further contributed to the market's growth.

4. Reimbursements for IHC Tests: The availability of reimbursements for IHC tests in various healthcare systems has encouraged healthcare providers and patients to opt for this diagnostic method, driving market expansion.

Kits Segment Leads Market Growth

In 2022, the Kits product segment exhibited the highest growth rate in the Immunohistochemistry Market. The demand for comprehensive solutions from reliable providers, offering closed-system reagents with calibrated measurements, has grown substantially. Diagnostic laboratories, hospitals, research institutes, and other end users are increasingly seeking all-in-one kits to streamline their processes.

Forensics Applications: A Niche Segment with Potential

While forensics applications represented the smallest share of the IHC market in 2022, their significance cannot be underestimated. IHC plays a crucial role in determining the cause of death, particularly in cases of age-related brain diseases and trauma. Post-mortem IHC helps ascertain the roles of various factors in the cause of death, including Alzheimer's disease and strokes.

Hospitals & Diagnostic Laboratories Lead End Users

Among end users, hospitals & diagnostic laboratories emerged as the largest segment in 2022. The growth of this segment is driven by the increasing number of specialty diagnostic tests conducted in hospital laboratories, the rising trend of in-house diagnostic procedures, and the establishment of in-house diagnostic capabilities in hospitals to offer prompt and affordable patient services.

Asia Pacific: The Epicenter of Growth

Asia Pacific (APAC) is projected to be the fastest-growing region in the Immunohistochemistry Market during the forecast period. Factors such as economic growth, a large population base, rising chronic disease prevalence, improving living standards, increased healthcare spending, government initiatives, and growing awareness of IHC tests are propelling market growth in the region.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939

Prominent Players in the Market

Leading players in the global Immunohistochemistry Market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US).

With the Immunohistochemistry Market poised for substantial growth, stakeholders in the healthcare and diagnostics sectors should closely monitor this dynamic landscape, which offers promising opportunities for advancements in medical diagnostics and patient care.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Article source: https://article-realm.com/article/Business/51549-Global-Immunohistochemistry-Market-is-Projected-to-Reach-USD-4-7-Billion-by-2028.html